NCT03142737

Brief Summary

The investigators will determine effects of different sources of protein on whole-body net protein synthesis and muscle protein synthesis in young healthy participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 2, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 5, 2017

Completed
3 days until next milestone

Study Start

First participant enrolled

May 8, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 6, 2018

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2019

Completed
Last Updated

September 3, 2024

Status Verified

June 1, 2019

Enrollment Period

10 months

First QC Date

May 2, 2017

Last Update Submit

August 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Net protein synthesis rate

    Net protein synthesis rate is determined in the 4.5-hour basal fasted period and 4-hous post-meal period over the 8.5-hour experimental period

    Up to 8.5 hours

Study Arms (5)

Red kidney bean intake

EXPERIMENTAL

Subjects will consume 1/2 cup of cooked red kidney bean following diet normalization for 3 days.

Other: Red kidney bean intake

Eggs intake

EXPERIMENTAL

Subjects will consume 2 cooked large eggs following diet normalization for 3 days.

Other: Eggs intake

Peanut butter intake

EXPERIMENTAL

Subjects will consume 2 tablespoons of peanut butter following diet normalization for 3 days.

Other: Peanut butter intake

Ground beef intake

EXPERIMENTAL

Subjects will consume 2 ounces of 90% lean ground beef following diet normalization for 3 days.

Other: Ground beef intake

Intact beef intake

EXPERIMENTAL

Subjects will consume 2 ounces of intact beef following diet normalization for 3 days.

Other: Intact beef intake

Interventions

Each participant will consume 1/2 cup of cooked red kidney bean

Red kidney bean intake

Each participant will consume 2 cooked large eggs.

Eggs intake

Each participant will consume 2 tablespoons of peanut butter.

Peanut butter intake

Each participant will consume 2 ounces of 90% lean ground beef.

Ground beef intake

Each participant will consume 2 ounces of intact beef.

Intact beef intake

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Men and women, ages 20-40 years
  • BMI from 20 to 29.9 kg/m2

You may not qualify if:

  • Current diagnosis of diabetes
  • History of malignancy in the 6 months prior to enrollment
  • History of gastrointestinal bypass surgery
  • History of a chronic inflammatory condition or other chronic diseases (Lupus, HIV/AIDS, etc)
  • Female subjects who are currently pregnant
  • Subjects who are unable to eat animal protein
  • Subjects who are unable to stop eating protein or Amino Acid (AA) supplements during the participation
  • Subjects who report regular resistance training (more than twice per week)
  • Subjects who have concomitant use of corticosteroids (ingestion, injection or transdermal)
  • Hemoglobin less than 9.5 g/dL at the screening visit
  • Platelets less than 250,000 at the screening visit.
  • Any other disease or condition that would place the subject at increased risk of harm if they were to participate, at the discretion of the study physician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72202, United States

Location

Study Officials

  • Robert Wolfe, PhD

    University of Arkansas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2017

First Posted

May 5, 2017

Study Start

May 8, 2017

Primary Completion

March 6, 2018

Study Completion

May 15, 2019

Last Updated

September 3, 2024

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations